Brodsky Sergey V, Satoskar Anjali, Chen Jun, Nadasdy Gyongyi, Eagen Jeremiah W, Hamirani Mirza, Hebert Lee, Calomeni Edward, Nadasdy Tibor
Department of Pathology, The Ohio State University, Columbus, OH 43210, USA.
Am J Kidney Dis. 2009 Dec;54(6):1121-6. doi: 10.1053/j.ajkd.2009.04.024. Epub 2009 Jul 4.
Acute kidney injury (AKI) during warfarin therapy usually is hemodynamic secondary to massive blood loss. Here, we report pathological findings in kidney biopsy specimens from 9 patients with warfarin overdose, hematuria, and AKI. Kidney biopsy specimens from patients on warfarin therapy with AKI were identified in our database within a 5-year period. Each kidney biopsy specimen was evaluated by using semiquantitative morphometric techniques, and medical history was reviewed for conditions explaining AKI. Biopsy specimens with morphological findings of active glomerulonephritis and active inflammatory lesions were excluded from the study. Biopsy specimens from 9 patients were selected. At presentation with AKI, each patient had an abnormal international normalized ratio (mean 4.4 +/- 0.7 IU) and increased serum creatinine level (mean, 4.3 +/- 0.8 mg/dL). Morphologically, each biopsy specimen showed evidence of acute tubular injury and glomerular hemorrhage: red blood cells (RBCs) in Bowman space and numerous occlusive RBC casts in tubules. Each biopsy specimen showed chronic kidney injury. Six of 9 patients did not recover from AKI. These data suggest that warfarin therapy can result in AKI by causing glomerular hemorrhage and renal tubular obstruction by RBC casts. Our experience suggests that this may be a potentially serious complication of warfarin therapy, especially in older patients with underlying chronic kidney injury.
华法林治疗期间的急性肾损伤(AKI)通常是大量失血继发的血流动力学改变所致。在此,我们报告9例华法林过量、血尿和AKI患者肾活检标本的病理结果。在我们的数据库中,在5年时间内确定了接受华法林治疗且发生AKI患者的肾活检标本。使用半定量形态计量技术对每个肾活检标本进行评估,并回顾病史以寻找可解释AKI的情况。具有活动性肾小球肾炎和活动性炎症病变形态学表现的活检标本被排除在研究之外。选择了9例患者的活检标本。在出现AKI时,每位患者的国际标准化比值均异常(平均4.4±0.7国际单位),血清肌酐水平升高(平均4.3±0.8mg/dL)。形态学上,每个活检标本均显示急性肾小管损伤和肾小球出血的证据:鲍曼间隙中有红细胞(RBC),肾小管中有大量闭塞性RBC管型。每个活检标本均显示慢性肾损伤。9例患者中有6例未从AKI中恢复。这些数据表明,华法林治疗可通过导致肾小球出血和RBC管型引起肾小管阻塞而导致AKI。我们的经验表明,这可能是华法林治疗的一种潜在严重并发症,尤其是在患有潜在慢性肾损伤的老年患者中。